TUESDAY, Nov. 28, 2023 (HealthDay News) — Transgender people transitioning to male (transmasculine) identity typically take testosterone therapy as part of the process. There have been worries that the treatment might spur erythrocytosis, an abnormally high concentration of red blood cells in blood that could prove dangerous. But newContinue Reading
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — Many breast cancer survivors take a hormonal drug after cancer treatment to stave off a recurrence, but new research suggests these drugs may be less effective in women who are obese. Breast cancer cells in hormone-positive breast cancers are fueled by the femaleContinue Reading
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — People with type 1 diabetes lack functional islet cells in their pancreas to produce the hormone insulin and must take daily insulin via injections or a continuous pump to compensate. But if new research pans out, some folks with type 1 diabetes mayContinue Reading
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Recent research has suggested that viruses could play a role in the loss of pancreatic beta cells, which triggers type 1 diabetes. Now, a new trial finds antiviral medications, when given soon after a child is diagnosed with type 1 diabetes, might helpContinue Reading
THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots. ExpertsContinue Reading
TUESDAY, Aug. 29, 2023 (HealthDay News) — Men’s testosterone levels remain pretty steady until age 70. After that, production of the male sex hormone starts to decline, new research indicates. This begs the question: Is testosterone loss among seniors really a function of the normal aging process? Or might itContinue Reading
MONDAY, July 17, 2023 (HealthDay News) — People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trialContinue Reading
TUESDAY, June 20, 2023 (HealthDay News) — In the face of an ongoing and widespread legal assault on transgender rights — one that threatens to cut off access to critical aspects of trans health care — a pair of new studies suggest that gender-affirming medical care is a lifesaving treatmentContinue Reading
FRIDAY, June 16, 2023 (HealthDay News) — Testosterone replacement therapy is safe for most men with heart problems who also have been diagnosed with a low testosterone disorder, a new clinical trial has concluded. The trial found that testosterone replacement did not raise these patients’ incidence of heart attack, strokeContinue Reading
TUESDAY, May 2, 2023 (HealthDay News) — The U.S. Food and Drug Administration is once again warning consumers to avoid muscle-building “supplements” that are anything but a safe alternative to steroids. In an advisory sent out last week, the agency said it continues to receive reports of serious side effectsContinue Reading